Skip to main content
. 2015 Jan 20;112(4):704–713. doi: 10.1038/bjc.2014.623

Table 2. Association of protein expression of actinin-4 and copy number increase in ACTN4 with clinicopathological characteristics of locally advanced pancreatic cancer.

 
Actinin-4 IHC
ACTN4 FISH
Characteristic Positive % Negative % P-value* Positive % Negative % P-value*
Median age, years (63.0)
 
 
 
 
0.159
 
 
 
 
0.41
 <63.0 36 54.5 9 36.0   9 60.0 36 47.4  
 ⩾63.0
30
45.5
16
64.0
 
6
40.0
40
52.6
 
Gender
 
 
 
 
0.6348
 
 
 
 
0.02
 Male 37 56.1 16 64.0   13 86.7 40 52.6  
 Female
29
43.9
9
36.0
 
2
13.3
36
47.4
 
PS
 
 
 
 
0.3506
 
 
 
 
0.679
 0 21 31.8 5 20.0   3 20.0 23 30.3  
 1 44 66.7 19 76.0   12 80.0 51 67.1  
 2
1
1.5
1
4.0
 
0
0.0
2
2.6
 
Tumour size
 
 
 
 
0.8647
 
 
 
 
1
 <37.4 mm 33 50.0 12 48.0   7 46.7 38 50.0  
 ⩾37.4 mm
33
50.0
13
52.0
 
8
53.3
38
50.0
 
Lymph node metastasis
 
 
 
 
0.4478
 
 
 
 
0.059
 Negative 48 72.7 16 64.0   7 46.7 57 75.0  
 Positive
18
27.3
9
36.0
 
8
53.3
19
25.0
 
Location of the tumour
 
 
 
 
0.0379
 
 
 
 
0.156
 Head of pancreas 31 47.0 18 72.0   10 66.7 33 43.4  
 Body or tail of pancreas
35
53.0
7
28.0
 
5
33.3
43
56.6
 
CA19-9
 
 
 
 
0.451
 
 
 
 
0.227
 <1000 U ml−1 43 65.2 19 76.0   8 53.3 54 71.1  
 ⩾1000 U ml−1
23
34.8
6
24.0
 
7
46.7
22
28.9
 
Therapy
 
 
 
 
1
 
 
 
 
1
 CT 25 37.9 9 36.0   6 40.0 28 36.8  
 CRT 41 62.1 16 64.0   9 60.0 48 63.2  

Abbreviations: ACTN4=actinin-4; CRT=chemoradiotherapy; CT=chemotherapy; FISH=fluorescence in situ hybridisation; IHC=immunohistochemistry; PS=Eastern Cooperative Oncology Group Performance Status.

*P-value: Fisher's exact test (two sided). Bold entries indicate statistically significance.